rTMS Treatment of Migraines: An Interrupted Time-Series Study Design

Presenting:
rTMS Treatment of Migraines: An Interrupted Time-Series Study Design

You’re invited to join the Clinical TMS Society for this installment of our Grand Rounds Webinar Series:  rTMS Treatment of Migraines: An Interrupted Time-Series Study Design by speaker Mahmoud (Max) Okasha, MD, MRCPsych, DPM, DLFAPA.

Learning objectives: 

• Explain how CSD is the most likely mechanism of pathogenesis in Migraines
• Discuss the treatment of migraines with rTMS
• Utilize an interrupted-time series design as an alternative to double blind active versus sham treatment 

Date: On-demand 

Format: Webinar using Zoom Video Communications

Cost: Members: $25 | Non-members $50

Speaker: Mahmoud (Max) Okasha, MD, MRCPsych, DPM, DLFAPA

Dr. Okasha is the Medical Director of Comprehensive Psychiatric Care, a private practice located in Norwich Connecticut where he is also the Primary Investigator (P.I.) and has conducted over 70 clinical trials. He is an Associate Clinical Professor at the Department of Psychiatry at Yale School of Medicine.

Enduring Material Learner Notification

Grand Round rTMS Treatment of Migraines: An Interrupted Time-Series Study Design Enduring Material

Acknowledgement of Financial Commercial Support

No financial commercial support was received for this educational activity.

Acknowledgement of In-Kind Commercial Support

No in-kind commercial support was received for this educational activity.

Satisfactory completion

Learners must complete an evaluation to receive a certificate of completion. You must participate in the entire activity as partial credit is not available. If you are seeking continuing education credit for a specialty not listed below, it is your responsibility to contact your licensing/certification board to determine course eligibility for your board requirement.  

Physicians          

In support of improving patient care, this activity has been planned and implemented by Amedco LLC and the Clinical TMS Society.  Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation Statement – Amedco LLC designates this enduring material activity for a maximum of 1 AMA PRA Category 1 Credit^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

International CME Accreditation

The American Medical Association has determined that physicians not licensed in the US who participate in this CME activity are eligible for 1 AMA PRA Category 1 Credit^TM.

ACCME / AMA PRA Category 1 Credit^TM carry reciprocity with EACCME member countries and most international licensing bodies for physicians, with some exceptions. Physicians should check with their country/board for eligibility.

Learning Objectives

1. Explain how CSD is the most likely mechanism of pathogenesis in Migraines
2. Discuss the treatment of migraines with rTMS
3. Utilize an interrupted-time series design as an alternative to double blind active versus sham treatment

Date of Release

June 15, 2018

Date of Expiration

June 14, 2021

Method of Physician Participation

Learners will listen to each audio self-directed module while following along with the visual slides. Upon completion, each learner will answer evaluation questions to receive their CME certificate.

Bibliographic Sources

Included on speaker slides

Disclosure of Conflict of Interest

The following table of disclosure information is provided to learners and contains the relevant financial relationships that each individual in a position to control the content disclosed to Amedco.  All of these relationships were treated as a conflict of interest and have been resolved.  (C7 SCS 6.1-­‐6.2, 6.5)

All individuals in a position to control the content of CE are listed below.